Nusinersen Injection (Nusinersen): a beacon of hope for spinal muscular atrophy patients, marketed under the name Spinraza, is a medication for the treatment of spinal muscular atrophy (SMA), a rare neuromuscular disorder. In December 2016,…
Conceptis is pleased to announce that the first prescriptions for the innovative drug Levulan® (Methylene Blue Enteric Delayed-release Tablets) have recently been issued nationwide, marking the first oral Methylene Blue Enteric-coated Extended-Release Tablets to be…
Merck Sharp & Dohme (Merck’s trade name) announced that its PD-1 inhibitor pembrolizumab (trade name: Koraida®) has been approved by the China National Drug Administration (NMPA) for the treatment of patients with the International Federation…
